Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001623632-25-000025
Filing Date
2025-01-08
Accepted
2025-01-08 13:38:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11119
2 atyrpharmaamend9exhibit1.htm EX-99 8609
3 atyrpharmaamend9exhibit2.htm EX-99 14334
4 atyrpharmaamend9exhibit3trd.htm EX-99 4196
5 atyrpharmaamend9exhibit3acd.htm EX-99 4156
  Complete submission text file 0001623632-25-000025.txt   44475
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Subject) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88839 | Film No.: 25517746
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)